Cipla Ltd
Bevacizumab (25mg/ml)
Syndyma 400mg/16ml Injection is an anticancer medication used to treat various types of cancer, including colon and rectum, non-small cell lung, kidney, brain, ovarian, and cervical cancer.
Solution for Infusion
Syndyma 400mg/16ml Injection is an effective medicine and first-line option when used together with other cancer medicines. It is given as an infusion, and your doctor will decide your dose and duration. You may experience side effects such as rectal bleeding, taste change, and headache. Inform your doctor if you notice any unusual bleeding or bleeding that doesn't stop easily. You may be advised to check blood pressure and levels of protein in urine while taking this medication.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Syndyma 400mg/16ml Injection is a anti-angiogenic medication that works by blocking a protein called vascular endothelial growth factor (VEGF), which stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
Syndyma 400mg/16ml Injection is an effective medicine First-line option when used together with other medicines for certain types of cancers Given as an infusion May lower wound healing ability May increase risk of bleeding